Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pediatrix Medical (MD) EBT (2016 - 2026)

Pediatrix Medical (MD) has disclosed EBT for 17 consecutive years, with $45.6 million as the latest value for Q4 2025.

  • Quarterly EBT rose 36.81% to $45.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $216.4 million through Dec 2025, up 313.57% year-over-year, with the annual reading at $216.4 million for FY2025, 313.57% up from the prior year.
  • EBT for Q4 2025 was $45.6 million at Pediatrix Medical, down from $87.8 million in the prior quarter.
  • The five-year high for EBT was $87.8 million in Q3 2025, with the low at -$167.7 million in Q2 2024.
  • Average EBT over 5 years is $14.2 million, with a median of $32.1 million recorded in 2023.
  • The sharpest move saw EBT surged 979.11% in 2021, then crashed 7386.89% in 2022.
  • Over 5 years, EBT stood at $53.5 million in 2021, then tumbled by 48.01% to $27.8 million in 2022, then plummeted by 599.03% to -$138.8 million in 2023, then soared by 124.0% to $33.3 million in 2024, then surged by 36.81% to $45.6 million in 2025.
  • According to Business Quant data, EBT over the past three periods came in at $45.6 million, $87.8 million, and $55.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.